FiercePharma11h
AbbVie’s Skyrizi rockets to top of TV drug ad spenders’ list with single largest monthly total this year
AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...
stocknews13h
3 Healthcare Stocks to Buy for the Aging Population Boom
The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene ...
FierceBiotech15h
Genmab axes 3 programs to focus on plumped-up pivotal pipeline
An influx of late-phase programs has prompted Genmab to reassess its bets. | An influx of late-phase programs has prompted Genmab to reassess its bets. The biotech is axing three early-stage clinical ...
Barchart on MSN15h
Are Wall Street Analysts Bullish on AbbVie Stock?
With a market cap of $356.2 billion, North Chicago, Illinois-based AbbVie Inc. (ABBV) operates in the pharmaceutical sector.